Literature DB >> 519932

Hypothesis for the individualisation of drug dosage.

J R Koup, C M Sack, A L Smith, M Gibaldi.   

Abstract

Computer simulations based on the pharmacokinetics of chloramphenicol and theophylline in patients, indicate a very strong correlation (r = 0.988 for chloramphenicol and r = 0.971 for theophylline) between log maintenance dose required to achieve a desired average drug concentration in serum at steady-state, and the drug concentration in serum 6 hours after an initial test dose administered by constant rate intravenous infusion over 0.5h. Accordingly, we have developed a nomogram to predict individual daily dosing requirements for these drugs in uncomplicated patients from a single serum assay following an initial dose. Within defined limits, predictions made with the nomogram are essentially equivalent to those made by iraditional pharmacokinetic methods which require substantially more drug concentration-time data following a test dose. Predictions based on the nomogram are relatively unaffected by small but typical errors in magnitude of the test dose, infusion time, sampling time and assay. Protocols for the administration of the test dose other than described, e.g. administration of an oral theophylline solution, may be equally useful for dosage predictions. In principle, this approach should apply to other drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519932     DOI: 10.2165/00003088-197904060-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  10 in total

1.  Digoxin pharmacokinetics: role of renal failure in dosage regimen design.

Authors:  J R Koup; W J Jusko; C M Elwood; R K Kohli
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

2.  Pharmacokinetic design of digoxin dosage regimens in relation to renal function.

Authors:  W J Jusko; S J Szefler; A L Goldfarb
Journal:  J Clin Pharmacol       Date:  1974-10       Impact factor: 3.126

3.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  An improved method of digoxin therapy.

Authors:  R W Jelliffe
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

5.  Improved enzymatic assay of chloramphenicol.

Authors:  A L Smith; D H Smith
Journal:  Clin Chem       Date:  1978-09       Impact factor: 8.327

Review 6.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Kinetic model for gentamicin dosing with the use of individual patient parameters.

Authors:  R J Sawchuk; D E Zaske; R J Cipolle; W A Wargin; R G Strate
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

8.  Theophylline kinetics in acute pulmonary edema.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

9.  Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.

Authors:  P M Loughnan; D S Sitar; R I Ogilvie; A Eisen; Z Fox; A H Neims
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

10.  Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.

Authors:  M Fixley; D D Shen; D L Azarnoff
Journal:  Am Rev Respir Dis       Date:  1977-06
  10 in total
  15 in total

Review 1.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

2.  Ethical considerations in the conduct of clinical pharmacokinetic studies.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Poor correlation between single-dose data and steady-state kinetics for phenobarbitone, primidone, carbamazepine and sodium valproate in children during monotherapy. Possible reasons for the lack of correlation.

Authors:  J A Armijo; J L Herranz; R Arteaga; R Valiente
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 4.  Feedback control methods for drug dosage optimisation. Concepts, classification and clinical application.

Authors:  S Vozeh; J L Steimer
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

Review 5.  Limited-sampling models for anticancer agents.

Authors:  L J van Warmerdam; W W ten Bokkel Huinink; R A Maes; J H Beijnen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

7.  Saliva theophylline concentrations after a single oral dose.

Authors:  J Culig; A Johnston; P Turner
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

8.  Prediction of maintenance dose required to attain a desired drug concentration at steady-state from a single determination of concentration after an initial dose.

Authors:  J T Slattery; M Gibaldi; J R Koup
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

9.  Rapid estimation of chloramphenicol clearance in infants and children.

Authors:  J R Koup; C M Sack; A L Smith; N N Neely; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

10.  Prediction of optimum oral theophylline dose in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.